[
  {
    "ts": null,
    "headline": "Organon Secures FDA Approval Extending NEXPLANON Use to Five Years",
    "summary": "OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy across body weights.",
    "url": "https://finnhub.io/api/news?id=c34a02b425aa04a4a4bfd7f86eca8e1cfe89bdc921bfebb36b176c673a9194e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768925040,
      "headline": "Organon Secures FDA Approval Extending NEXPLANON Use to Five Years",
      "id": 138188701,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy across body weights.",
      "url": "https://finnhub.io/api/news?id=c34a02b425aa04a4a4bfd7f86eca8e1cfe89bdc921bfebb36b176c673a9194e8"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain CLOV Stock in Your Portfolio for Now",
    "summary": "Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.",
    "url": "https://finnhub.io/api/news?id=9570ffee1f46ed89404a88bec6314961f6bd73f52a6b5e271ba5d3d89eaa8580",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768924800,
      "headline": "Here's Why You Should Retain CLOV Stock in Your Portfolio for Now",
      "id": 138188702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.",
      "url": "https://finnhub.io/api/news?id=9570ffee1f46ed89404a88bec6314961f6bd73f52a6b5e271ba5d3d89eaa8580"
    }
  }
]